Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

innovation   publishing date : 2021 - 06 - 15    save search

ANI Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference 2021
Published: 2021-06-15 (Crawled : 01:00) - biospace.com/
ANIP S | $66.2 0.88% 19K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.0% C: -1.89%

conference health
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
Published: 2021-06-15 (Crawled : 01:00) - biospace.com/
AMPH | $40.89 1.79% 53K twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 1.16% C: 1.06%

conference health
Why is Technology So Lousy at Innovation
Published: 2021-06-15 (Crawled : 20:00) - thehackettgroup.com
HCKT 4 | $22.61 0.49% 17K twitter stocktwits trandingview |
Commercial Services
| | O: -0.11% H: 0.22% C: -1.23%

technology
Greenlight Capital Re, Ltd. Announces The Appointment Of Heejae Cho As Head Of Innovations Underwriting
Published: 2021-06-15 (Crawled : 17:00) - greenlightre.ky
GLRE 4 | $12.3 -1.05% 11K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 3.08% C: 2.49%


Cashless Tipping And Secure ID Verification Among Virgin Hotels' Latest Mobile App Innovation
Published: 2021-06-15 (Crawled : 16:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M twitter stocktwits trandingview |
Manufacturing
| | O: -1.17% H: 10.08% C: 7.22%

hotel mobile app test mobile
Purple Launches New Pillows, Helping Consumers Reinvent Summer Sleep
Published: 2021-06-15 (Crawled : 15:15) - prnewswire.com
PRPL | $1.6 6.67% 98K twitter stocktwits trandingview |
Miscellaneous
| | O: 0.7% H: 2.17% C: -2.22%


AT&T Cybersecurity Delivers New Managed SASE Solution to Drive Innovation and Transform User Experiences at the Edge
Published: 2021-06-15 (Crawled : 14:00) - prnewswire.com
T | $16.455 0.89% 18M twitter stocktwits trandingview |
Communications
| | O: -0.1% H: 0.83% C: 0.76%

security cybersecurity liver
Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021
Published: 2021-06-15 (Crawled : 13:00) - biospace.com/
LCTX | $1.165 2.19% 110K twitter stocktwits trandingview |
Health Technology
| | O: 1.02% H: 0.67% C: -3.02%

conference
Antares Pharma to Present at the Raymond James Human Health Innovations Conference
Published: 2021-06-15 (Crawled : 13:00) - globenewswire.com
ATRS | $5.59 0.0% twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.23% C: -1.9%

conference health pharma
Intercept to Present at the Raymond James 2021 Human Health Innovation Conference
Published: 2021-06-15 (Crawled : 12:00) - globenewswire.com
ICPT | $19.0 -0.05% 4M twitter stocktwits trandingview |
Health Technology
| | O: 0.23% H: 0.0% C: -3.55%

conference health
Autolus Therapeutics Announces Innovation Licensing and Access Pathway (ILAP) designation for obe-cel for the treatment of relapsed/refractory adult B-cell ALL
Published: 2021-06-15 (Crawled : 12:00) - biospace.com/
AUTL | $4.645 1.86% 310K twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 1.39% C: -3.3%

treatment license cel t-cell designation
PYC Therapeutics Establishing New U.S. Headquarters in San Diego, Announces Residency at Johnson & Johnson Innovation, JLABS
Published: 2021-06-15 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.575 0.31% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.38% C: -0.45%


Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference
Published: 2021-06-15 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 1.6% C: 1.22%

conference health
Clene to Present at the Raymond James Human Health Innovation Conference
Published: 2021-06-15 (Crawled : 12:00) - biospace.com/
CLNN S | $0.3311 -0.57% 160K twitter stocktwits trandingview |
| | O: -0.62% H: 3.23% C: -0.62%

conference health
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
Published: 2021-06-15 (Crawled : 05:00) - prnewswire.com
LLY | News | $742.04 1.46% 540K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.25% C: -1.14%

phase 2 china trial obesity
Gainers vs Losers
87% 13%

Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

MTC | $2.28 46.15% 2.6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.14 39.56% 7.6M twitter stocktwits trandingview |
Finance

VNRX | $0.8 33.33% 2.9M twitter stocktwits trandingview |
Health Technology

MLEC | $1.865 33.21% 2.4M twitter stocktwits trandingview |
n/a

PALI | $6.37 29.21% 21M twitter stocktwits trandingview |
Manufacturing

CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.